Product NDC: | 10631-113 |
Proprietary Name: | Ultravate PAC-Cream |
Non Proprietary Name: | halobetasol propionate |
Active Ingredient(s): | .5 mg/g & nbsp; halobetasol propionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 10631-113 |
Labeler Name: | Ranbaxy Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019967 |
Marketing Category: | NDA |
Start Marketing Date: | 20100210 |
Package NDC: | 10631-113-01 |
Package Description: | 275 g in 1 PACKAGE, COMBINATION (10631-113-01) |
NDC Code | 10631-113-01 |
Proprietary Name | Ultravate PAC-Cream |
Package Description | 275 g in 1 PACKAGE, COMBINATION (10631-113-01) |
Product NDC | 10631-113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | halobetasol propionate |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100210 |
Marketing Category Name | NDA |
Labeler Name | Ranbaxy Laboratories Inc. |
Substance Name | HALOBETASOL PROPIONATE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |